Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What systems can and can't do.

T Kenakin1

  • 1GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA. Terry.P.Kenakin@gsk.com

British Journal of Pharmacology
|January 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The tail wags the dog: possible mechanism for reverse allosteric control of ligand-activated channels.

British journal of pharmacology·2013
Same author

Overview of length-tension relationships in isolated tissue.

Current protocols in pharmacology·2011
Same author

Isolated cardiac muscle assays.

Current protocols in pharmacology·2011
Same author

Isolated blood vessel assays.

Current protocols in pharmacology·2011
Same author

β-Adrenoceptor assays.

Current protocols in pharmacology·2011
Same author

HIV fusion inhibitors for AIDS therapy.

Receptors & channels·2002
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
Same journal

The role of protein arginine methyltransferases in sickle cell-mediated neurovascular impairments in mice.

British journal of pharmacology·2026
Same journal

β-Cyclodextrin inclusion enhances the pro-resolving effects of the annexin A1 mimetic Ac2-26 in a mouse model of antigen-induced arthritis.

British journal of pharmacology·2026
See all related articles

This commentary explores histamine H(2) receptor antagonism, highlighting how agonist-dependent effects reveal mechanisms beyond simple orthosteric blockade. Quantitative pharmacology differentiates receptor interaction models.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Histamine H(2) receptors play crucial roles in various physiological processes.
  • Understanding receptor antagonism is key to developing targeted therapeutics.
  • Orthosteric antagonism is the most common model, where antagonists block agonists at the primary binding site.

Discussion:

  • This commentary examines Dr. Jillian Baker's work on histamine H(2) receptor antagonism.
  • It highlights the use of pharmacological principles to elucidate receptor system capabilities.
  • The discussion contrasts orthosteric and allosteric antagonism models, emphasizing agonist-dependent effects.

Key Insights:

  • Quantitative assessment of antagonism can reveal agonist dependence, suggesting mechanisms beyond orthosteric blockade.

Related Experiment Videos

  • A permissive allosteric model allows for agonist-antagonist dialogue, where agonist type influences antagonist effect magnitude.
  • Histamine H(2) receptors, unlike beta-adrenoceptors, appear to follow a simpler orthosteric antagonism model.

    • Outlook:

    • Further quantitative receptor pharmacology studies can elucidate the molecular mechanisms of drug-receptor interactions.
    • Differentiating between orthosteric and allosteric antagonism is crucial for drug design.
    • This work provides a framework for understanding complex receptor pharmacology and its implications for drug development.